Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

mark-porter-dr_2161169b

Doctors’ union the BMA appoints new chairman

July 2, 2012 Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment

Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …
Appointment
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …
Feature
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012 Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
News
ariad_slideshow-3

Ariad touts next generation CML treatment

June 29, 2012 Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland

Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …
News

MRN gets SMART with its clinical trial scheduling

June 28, 2012 Research and Development clinical trials, electronic data capture, medical research network, mrn, patient scheduling

Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial and site nurse support as well …
News
Press release

Astellas submits new prostate cancer drug to EMA

June 28, 2012 Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …
News

Amylin withheld safety data, says FDA

June 27, 2012 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …
News

Roche cuts 1,000 R&D jobs

June 27, 2012 Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
News
Roche image

Roche’s Perjeta increases survival

June 27, 2012 Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …
News

Steve Bates appointed chief executive of the BioIndustry Association

June 25, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates

The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …
Appointment

The European Medicines Group: focused on UK market access

June 25, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access

Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …
Feature

Takeda makes changes to organisation

June 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda has announced the change of senior leadership and the establishment of a new organisation.Effective from July Masahiro Fujimaki becomes …
Appointment
AstraZeneca image

AstraZeneca buys Ardea Biosciences

June 22, 2012 Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda

AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …
News

Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions

June 21, 2012 Manufacturing and Production, Research and Development

Seattle, Wash., and Somerset N.J., (June 20, 2012)  — Frazier Healthcare and Catalent Pharma Solutions, Inc., today announced they have closed …
News
Press release
juliastrakerpress-11

New head of strategic planning for PAN advertising

June 21, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Indigenus, Med Comms, Pan Advertising, appointment

Julia Straker has been appointed head of strategic planning at medical communciations agency PAN Advertising.  Julia joins from TBWA\Paling Walters …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026